Publications by authors named "Debra K Czerwinski"

28Publications

CD81 is a novel immunotherapeutic target for B cell lymphoma.

J Exp Med 2019 07 23;216(7):1497-1508. Epub 2019 May 23.

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA

View Article and Find Full Text PDF
July 2019

T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular Proteins.

Proteomics 2018 06 18;18(12):e1700410. Epub 2018 Apr 18.

Department of Chemical and Systems Biology, Stanford Medicine, Stanford, CA, USA.

View Article and Find Full Text PDF
June 2018

Eradication of spontaneous malignancy by local immunotherapy.

Sci Transl Med 2018 01;10(426)

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

View Article and Find Full Text PDF
January 2018

Holbrook Kohrt: In Memoriam (1977-2016).

Clin Cancer Res 2016 07;22(14):3695-6

Drug Development Department, INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.

View Article and Find Full Text PDF
July 2016

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK.

Proc Natl Acad Sci U S A 2015 Mar 17;112(9):E966-72. Epub 2015 Feb 17.

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305-5151; and

View Article and Find Full Text PDF
March 2015

Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma.

Blood 2015 Mar 6;125(13):2079-86. Epub 2015 Feb 6.

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA.

View Article and Find Full Text PDF
March 2015

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.

Proc Natl Acad Sci U S A 2010 Jul 11;107(29):12747-54. Epub 2010 Jun 11.

Department of Medicine, Oncology Division, Stanford University, Stanford, CA 94305, USA.

View Article and Find Full Text PDF
July 2010

Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees.

Blood 2009 Nov 17;114(20):4477-85. Epub 2009 Sep 17.

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article and Find Full Text PDF
November 2009

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.

Blood 2009 Jan 23;113(1):85-94. Epub 2008 Sep 23.

Division of Oncology, Department of Medicine, Stanford University Medical Center, CA.

View Article and Find Full Text PDF
January 2009

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.

J Immunol 2007 Aug;179(4):2493-500

Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA 94305, USA.

View Article and Find Full Text PDF
August 2007

Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry.

J Immunol 2006 Aug;177(3):1581-9

Department of Medicine, Oncology Division, Stanford University, Stanford, CA 94305, USA.

View Article and Find Full Text PDF
August 2006

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.

Blood 2006 Nov 11;108(9):3135-42. Epub 2006 Jul 11.

Department of Medicine, Oncology Division, Baxter Laboratory for Genetic Pharmacology, Stanford University Medical Center, Stanford, CA 94305-5151, USA.

View Article and Find Full Text PDF
November 2006

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.

N Engl J Med 2004 Apr;350(18):1828-37

Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, Calif, USA.

View Article and Find Full Text PDF
April 2004